Watch Ticker

Guardant Health, Inc. Common Stock

Go to Guardant Health, Inc. Common Stock Website

$41.42

0.00 (0.00%)

Live

Previous Close

$41.42

Day Range

$0 - $0

Previous Day Range

$40.355 - $42.22

Market Cap

$5.2 billion USD

Day Vol.

Previous Day Vol.

3.2 million

Currency

USD

Primary Exchange

Nasdaq

Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CD...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Jesterai - Guardant Health (GH) Q2 Revenue Up 31%

Guardant Health reported strong Q2 2025 financial results, with revenue of $232.1 million (31% YoY growth), beating analyst estimates. The company saw significant progress in its oncology diagnostics and Shield screening business, raising full-year guidance to $915-$925 million.

Related tickers: GH.

Read Full Article

Researchandmarkets.Com - Minimal Residual Disease Testing Market Trends Analysis Report 2025-2030 | North America Leads in MRD Testing Market with Advanced Reimbursement Ecosystem

The global Minimal Residual Disease (MRD) Testing Market is projected to reach $4.50 billion by 2030, with a 10.1% CAGR, driven by increasing cancer diagnostic needs and personalized medicine approaches.

Related tickers: EXAS, GRAL, GH, RHHBY.

Read Full Article

Trending Tickers

Please sign in to view